1998
DOI: 10.1016/s0006-2952(98)00088-4
|View full text |Cite
|
Sign up to set email alerts
|

Opioid analgesics as noncompetitive N-methyl-d-aspartate (NMDA) antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
70
0
1

Year Published

2005
2005
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 152 publications
(73 citation statements)
references
References 50 publications
2
70
0
1
Order By: Relevance
“…93 However, its long half-life (24-36 hours) necessitates extremely careful dose titration. 94 Two small RCTs of methadone demonstrated benefit in managing neuropathic pain, 95,96 and open-label experience suggests promise in a wide variety of neuropathic pain conditions.…”
mentioning
confidence: 99%
“…93 However, its long half-life (24-36 hours) necessitates extremely careful dose titration. 94 Two small RCTs of methadone demonstrated benefit in managing neuropathic pain, 95,96 and open-label experience suggests promise in a wide variety of neuropathic pain conditions.…”
mentioning
confidence: 99%
“…These multiple action mechanisms give it advantages over other opioids. NMDA antagonism is also believed to atenuate tolerance [12][13][14][15][16]. These combined mechanisms are the cause of its eicacy in chronic and neuropathic pain [17].…”
Section: Dual or Multimechanism Opioidsmentioning
confidence: 99%
“…13 The degree of NMDA antagonism produced by methadone is similar to that of ketamine. 14 Methadone is characterized by its high inter-individual variability. A good understanding of the pharmacokinetics and pharmacodynamics is imperative to the safe use of this medication.…”
Section: Conclusion : La Méthadone Est Un Opiacé Aux Propriétés Complmentioning
confidence: 99%